Related Experiment Video
Updated: May 29, 2026
08:27
Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
Statistical Optimization of Pharmacogenomics Association Studies: Key Considerations from Study Design to Analysis
Benjamin J Grady1, Marylyn D Ritchie
1Department of Molecular Physiology & Biophysics, Center for Human Genetics Research, Vanderbilt University, Nashville, TN, USA.
Current Pharmacogenomics and Personalized Medicine
|September 3, 2011
Summary
Pharmacogenomics research translates genetic discoveries into clinical practice for personalized medicine. This review examines study design, quality control, and interpretation to optimize the impact of genetic findings.
Area of Science:
- Human genetics
- Genetic epidemiology
- Pharmacogenomics
Background:
- Pharmacogenomics offers personalized medicine by linking genetic variations to drug response.
- Advancements in genotyping technology enable whole-genome studies for novel marker discovery.
- Evolving methodologies necessitate a discussion on applying new tools in genetic research.
Purpose of the Study:
- To review the design of pharmacogenomic association studies.
- To optimize the impact and utility of pharmacogenomic research.
- To consider key issues including ascertainment, genotyping, quality control, analysis, and interpretation.
Main Methods:
- Examination of pharmacogenomic association study designs.
- Review of quality control criteria for genome-wide association studies (GWAS).
- Consideration of factors influencing translation of genetic discoveries.
Main Results:
- Several pharmacogenomic associations have been replicated and translated into clinical practice.
- Understanding of systematic errors in genotyping has refined quality control.
- Examples illustrate the evidence required for successful genetic discovery translation.
Conclusions:
- Optimizing pharmacogenomic study design is crucial for effective personalized medicine.
- Rigorous quality control and appropriate analysis are essential for reliable results.
- Successful translation requires robust evidence to guide therapeutic decisions.
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...